These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6211134)

  • 61. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
    Beskid G; Fallat V; Siebelist J; Durkin JW; Lipschitz ER; McGarry DH
    J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Susceptibility of gram-negative aerobic bacilli resistant to carbenicillin in a general hospital to piperacillin and ticarcillin.
    McGowan JE; Terry PM
    Antimicrob Agents Chemother; 1979 Jan; 15(1):137-39. PubMed ID: 426501
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Laboratory and clinical studies on cefsulodin (author's transl)].
    Kumasaka Y; Nakahata H; Endo K; Sasaki K; Matsuhashi A; Narita S; Imamura K; Takebe K; Masaki N; Tamura T
    Jpn J Antibiot; 1981 Oct; 34(10):1416-21. PubMed ID: 6460884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro activity of carbenicillin, ticarcillin, sisomicin and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Watanakunakorn C; Glotzbecker C
    Chemotherapy; 1978; 24(6):343-6. PubMed ID: 100282
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of ticarcillin and carbenicillin activity against random and select populations Pseudomonas aeruginosa.
    Prior RB; Fass RJ
    Antimicrob Agents Chemother; 1978 Feb; 13(2):184-7. PubMed ID: 417671
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical laboratory approach for estimating effective administrative dose of cefsulodin].
    Uete T; Matsuo K
    Jpn J Antibiot; 1984 Sep; 37(9):1652-60. PubMed ID: 6439909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
    Gwynn MN; Rolinson GN
    Infection; 1980; 8(2):73-80. PubMed ID: 6771215
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
    Fernandes CJ; Stevens DA; Ackerman VP
    Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1981 Mar; 19(3):407-13. PubMed ID: 6972728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa.
    Philippon A; Paul G; Nevot P
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():119-22. PubMed ID: 19810173
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.
    White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG
    Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Dibb WL; Asphaug Kjellevold V; Digranes A
    Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
    Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
    Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.